Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2002
06/06/2002WO2002043647A2 Oncolytic virus
06/06/2002WO2002043586A1 Method and device for measuring body compositions
06/06/2002WO2002043478A2 Transgenic transchromosomal rodents for making human antibodies
06/06/2002WO2002043477A1 Method of constructing mouse suitable for the take, differentiation and proliferation of heterogenous cells, mouse constructed by this method and use of the mouse
06/06/2002WO2002020792A8 Efflux protein dep33 of corynebacterium glutamicum
06/06/2002WO2002020726A3 Method for increasing the effectiveness of antiinfective agents
06/06/2002WO2002016440A3 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections
06/06/2002WO2002014860A8 Functional protein arrays
06/06/2002WO2002014473A3 Animals expressing exogenous igf-i in their milk
06/06/2002WO2002013606A3 Improved insecticidal bacteria, and methods for making and using them
06/06/2002WO2002006510A3 Photoselection of nucleic acid ligands
06/06/2002WO2002005843A3 Human rrp sequences and methods of use
06/06/2002WO2002002606A3 Immunisation against chlamydia pneumoniae
06/06/2002WO2002000906A3 Replication deficient adenoviral tnf vector
06/06/2002WO2002000855A3 Regulation of human s-acyl fatty acid synthase thioesterase-like enzyme
06/06/2002WO2001098359A3 Cyr61 as a target for treatment and diagnosis of breast cancer
06/06/2002WO2001098340A3 Regulation of human mast cell protease 6-like enzyme
06/06/2002WO2001096583A3 Removal of selectable markers from transformed cells
06/06/2002WO2001096557A3 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same
06/06/2002WO2001096542A3 A human aminotransferase (23680) and uses thereof
06/06/2002WO2001096538A3 Regulation of human transmembrane serine protease
06/06/2002WO2001094414A3 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE
06/06/2002WO2001094385A8 Human hm74-like g protein coupled receptor
06/06/2002WO2001092524A3 Myosin-like gene expressed in human heart and muscle
06/06/2002WO2001092305A3 Mammalian transforming growth factor beta-10
06/06/2002WO2001090389A3 Production of silk-like proteins in plants
06/06/2002WO2001090360A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/06/2002WO2001090334A3 Drug metabolizing enzymes
06/06/2002WO2001090329A3 A novel human acyltransferase family member and uses thereof
06/06/2002WO2001088173A3 Methods for the enzymatic assembly of polynucleotides and identification of polynucleotides having desired characteristics
06/06/2002WO2001088167A3 Spike tissue-specific promoter
06/06/2002WO2001088116A9 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
06/06/2002WO2001087238A3 Induction of apoptosis and cell growth inhibition by protein 4.33
06/06/2002WO2001085901A3 Microphysiometer
06/06/2002WO2001083732A3 Databases of regulatory sequences; methods of making and using same
06/06/2002WO2001081601A3 Manipulation of min genes in plants
06/06/2002WO2001081565A3 Sleeping beauty, a transposon vector with a broad host range for the genetic transformation in vertebrates
06/06/2002WO2001080840A3 Cytotoxic agents comprising single-stranded and/or looped dna
06/06/2002WO2001079472A3 Nucleic acid sequences to proteins involved in tocopherol synthesis
06/06/2002WO2001079466A3 Regulation of human epithin-like serine protease
06/06/2002WO2001079442A3 Albumin fusion proteins
06/06/2002WO2001075453A3 Methods involving induced dimerisation by cellular components
06/06/2002WO2001075178A3 Methods for identifying peptide aptamers capable of altering a cell phenotype
06/06/2002WO2001075132A3 Method for producing authentic cytokines in plants
06/06/2002WO2001074998A3 Novel polypeptide - a human protein hydrolytic enzyme regulatory protein 10 and polynucleotide encoding it
06/06/2002WO2001074997A3 Novel polypeptide - a human cannabis alcohol receptor protein 11 and polynucleotide encoding it
06/06/2002WO2001074128A3 A novel polypeptide, microtubulin 11 and the polynucleotide encoding the polypeptide
06/06/2002WO2001072973A3 Regulation of human heparanase-like enzyme
06/06/2002WO2001072784A3 Peptides binding to non-acetylated h3 and h4 histones for cancer therapy
06/06/2002WO2001072323A3 Use of insulin for the treatment of cartilagenous disorders
06/06/2002WO2001068849A3 Human ion channels
06/06/2002WO2001067129A3 Epoxide polymer surfaces
06/06/2002WO2001066756A9 22105, a human thioredoxin family member and uses thereof
06/06/2002WO2001064907A3 Lipid metabolism enzymes
06/06/2002WO2001064884A3 G12l, a gene associated with the thermal response
06/06/2002WO2001051652A3 Method for identifying a mark applied on a solid body
06/06/2002WO2001049886A3 Method of analyzing a nucleic acid
06/06/2002WO2001049324A3 Novel colloid synthetic vectors for gene therapy
06/06/2002WO2001048209B1 Genes identified as required for proliferation of e. coli
06/06/2002WO2001046445A3 Production of transgenic plants of the tagetes species
06/06/2002WO2001044516A3 Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated rna decay
06/06/2002WO2001042497A9 Monitoring oligonucleotide binding processes using chemiluminescence quenching
06/06/2002WO2001036645A3 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
06/06/2002WO2001032922A3 Methods for detection of a target nucleic acid sequence
06/06/2002WO2001031014A3 G protein-coupled receptors expressed in human brain
06/06/2002WO2001023604A9 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
06/06/2002WO2001021810B1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/06/2002WO2001016325A9 Plant reproduction proteins
06/06/2002WO2000078935A9 Mevalonate pathway genes
06/06/2002WO2000074630A3 Dna vaccine for protecting an avian against infectious bursal disease virus
06/06/2002WO2000068429A3 Diagnosis of glaucoma
06/06/2002WO2000024782A3 Modified peptides, comprising an fc domain, as therapeutic agents
06/06/2002WO2000022430A3 Neisseria genomic sequences and methods of their use
06/06/2002US20020069434 Nucleotide sequences for use in the generation of disease resistant plants
06/06/2002US20020069433 Amplifying reproduction of preferential plants; obtain cells, transform, express vector, propagate plant, monitor enzymatic activity of plant
06/06/2002US20020069432 Signal transduction stress-related proteins and methods of use in plants
06/06/2002US20020069431 Effect of endochitinase and chitobiosidase and their encoding genes on plant growth and development
06/06/2002US20020069430 Transgenic plants that exhibit enhanced nitrogen assimilation
06/06/2002US20020069429 Method for conferring herbicide, pest, or disease resistance in plant hosts
06/06/2002US20020069428 Genes encoding scip-1 orthologs and methods of use
06/06/2002US20020069427 Arthropod defensins
06/06/2002US20020069426 Methyl-D-erythritol phosphate pathway genes
06/06/2002US20020069425 Methods and genetic compositions to limit outcrossing and undesired gene flow in crop plants
06/06/2002US20020069424 Protein-protein interactions in neurodegenerative disorders
06/06/2002US20020069423 Prion-free transgenic ungulates
06/06/2002US20020069422 Proteins for use in the treatment of trypanosome infection, cancer, inflammation and immunological defects
06/06/2002US20020068825 Polypeptide for use in the treatment of nervous system disorders
06/06/2002US20020068824 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects
06/06/2002US20020068823 33877 and 47179, novel human glycosyltransferase family members and uses thereof
06/06/2002US20020068822 Dwf7 mutants
06/06/2002US20020068821 Separating nucleotide sequences from sample; obtain samples, form complexes, recover nucleotide sequences
06/06/2002US20020068820 Hpv-specific oligonucleotides
06/06/2002US20020068816 For diagnosis, prevention or treatment of cancer, AIDS, immunodeficiencies, autoimmune diseases, inflammatory diseases, and proliferative diseases
06/06/2002US20020068716 Pituitary-tumor-transforming-gene (PTTG) polypeptide expressed by pituitary tumor cells, which binds anti-PTTG antibody.
06/06/2002US20020068714 Screening for agents that modulate tolerance to an immunogen; delivering a nucleic acid that directs expression of the immunogen to the liver of an animal, resulting in sustained expression of the immunogen in the liver.
06/06/2002US20020068713 Genetic engineering of vascular grafts to resist disease
06/06/2002US20020068711 Arrest of proliferation of highly glycolytic tumors
06/06/2002US20020068710 20685, 579, 17114, 23821, 33894 and 32613, novel human transporters
06/06/2002US20020068709 Modulating expression of a gene involved in malignant cell growth, comprising contacting with an oligonucleotide that comprises one or more locked nucleic acid units
06/06/2002US20020068707 Iga nephropathy-related genes
1 ... 2792 2793 2794 2795 2796 2797 2798 2799 2800 2801 2802 2803 2804 2805 2806 2807 2808 2809 2810 2811 2812 ... 4023